Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 35Colonic Neoplasms 14Colorectal Neoplasms 13Rectal Neoplasms 11Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Endometrial Neoplasms 8Uterine Cervical Neoplasms 7Obesity 7Motor Activity 7Lung Neoplasms 7Overweight 6Depression 6Small Cell Lung Carcinoma 5Ovarian Neoplasms 5Fatigue 5Breast Carcinoma In Situ 5Anxiety Disorders 5Tobacco Use Disorder 4Sexuality 4Sexual Dysfunction, Physiological 4Pancreatic Neoplasms 4Leukemia, Myeloid, Acute 4Carcinoma, Intraductal, Noninfiltrating 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3

Interventions

Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Castration-Resistant Prostate Cancer (CRPC) × Counseling × Clear all
NCT07240857 2026-05-22

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

Zhejiang University

Phase EARLY_PHASE1 Enrolling by invitation
18 enrolled
Genitourinary

Castration-Resistant Prostate Cancer (CRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡